N
TRHC

Nuveen’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Nuveen’s Portfolio TRHC Stock Details TRHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-68,821
Closed -$354K – 3560
2022
Q1 		$354K Buy
68,821
+504
+0.7% +$4.52K ﹤0.01% 3089
2021
Q4 		$950K Sell
68,317
-5,488
-7% -$99.9K ﹤0.01% 2878
2021
Q3 		$2.27M Sell
73,805
-2,113
-3% -$77.8K ﹤0.01% 2614
2021
Q2 		$3.8M Buy
75,918
+4,000
+6% +$179K ﹤0.01% 2389
2021
Q1 		$3.31M Buy
71,918
+1,181
+2% +$56.4K ﹤0.01% 2370
2020
Q4 		$3.03M Sell
70,737
-1,824
-3% -$69.2K ﹤0.01% 2302
2020
Q3 		$2.96M Sell
72,561
-1,318
-2% -$65.6K ﹤0.01% 2191
2020
Q2 		$4.04M Sell
73,879
-3,355
-4% -$192K ﹤0.01% 2020
2020
Q1 		$4.04M Buy
77,234
+8,877
+13% +$481K ﹤0.01% 1841
2019
Q4 		$3.33M Sell
68,357
-1,136
-2% -$53.2K ﹤0.01% 2200
2019
Q3 		$3.82M Buy
69,493
+1,419
+2% +$81.2K ﹤0.01% 2106
2019
Q2 		$3.4M Buy
+68,074
New +$3.39M ﹤0.01% 2187
2019
Q1 		– Sell
-18,943
Closed -$1.21M – 1092
2018
Q4 		$1.21M Buy
18,943
+3,330
+21% +$236K 0.01% 685
2018
Q3 		$1.27M Sell
15,613
-3,513
-18% -$257K 0.01% 721
2018
Q2 		$1.22M Buy
+19,126
New +$938K 0.01% 699

Other funds holding TRHC

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RP
Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Nuveen's TRHC Position: Q2 2022 in Review

Nuveen sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q2 2022, closing a stake of 68,821 shares — an estimated $354K sold.

Nuveen first reported a position in TRHC in Q2 2018 and held it in 15 quarters. The position peaked at $4.04M in Q2 2020. 96 funds tracked by Wall St. Rank hold TRHC as of Q2 2022.

  • Nuveen reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 68,821 Tabula Rasa HealthCare, Inc. Common Stock shares in Q2 2022, an estimated $354K.
  • Nuveen first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2018 and held it in 15 quarters.
  • Nuveen's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $4.04M in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.